Since insulin resistance contributes greatly to the metabolic syndrome and is the major cause of type 2 diabetes mellitus, treatment with insulin sensitizers may ameliorate the pathophysiological abnormalities of the metabolic syndrome [26]. This evidence concerns the gene INS and Insulin resistance.